announcements

CAREERS

 

The Institute Albert Bonniot seeks highly qualified applicants in the field of Cancer Translational Research for a 3-year professor position, extendable to a permanent professor position at the University Joseph Fourier and the University Hospital of Grenoble.  More information.

 

IASLC FELLOWSHIP AND YOUNG INVESTIGATOR PROGRAMS

The International Association for the Study of Lung Cancer is proud to announce the annual IASLC Fellowship and Young Investigators Programs.

 

Applications are now requested for the 2013 – 2014 Fellowship and Young Investigator award cycle. Overall, there will be a minimum of three awards of $40,000 per year, each for a duration of two years (total $80,000 per grant), with at least one recipient from each region (North America, Europe and Rest of the World) funded. The Prevent Cancer Foundation (PCF) will jointly sponsor awards focused on lung cancer prevention and translational research, supported through educational grants.

 

Application forms can be found on the Fellowship Guidelines Page.

 

For information in other languages, please download the Announcement in Spanish, Chinese or Japanese.

 

 

In Memorium: Heine Hoi Hansen, MD 1938-2011

 

 

 

 

It with deep sadness the IASLC received the message that one of its founders, Prof. Heine Hoi Hansen, passed away in Copenhagen on September 16, 2011.  Prof. Hansen was instrumental in the development of the IASLC.  May his legacy be a blessing for the new generation of lung cancer investigators and all the patients waiting for new developments!

 

 

International Multidisciplinary Classification of Lung Adenocarcinoma

 

The IASLC, with the support and scientific oversight of the American Thoracic Society and the European Respiratory Society, in February 2011 published a new international multidisciplinary classification of lung adenocarcinoma, the first revision to the classification in six years.

 

 

Career Opportunities in Thoracic Oncology

 

If you have a position to list on this website, please email your request with all of the pertinent information

 

 

 

A grand opportunity presents itself...

 

 Lung cancer remains the No. 1 cancer-killer of Americans. As part of its mission, the IASLC strives to use all available means to eliminate lung cancer as a health threat for the individual patient and throughout the world. In 2009, IASLC leaders were awarded a $5.2 million Grand Opportunities Grant by the American Recovery and Reinvestment Act (ARRA) and the National Cancer Institute to hold free genetic tumor screening for lung cancer patients at 13 sites across the country. Known as the Lung Cancer Mutation Consortium Protocol, the goal of the project is to assess mutations in lung adenocarcinoma tumors where oral therapies are specific, more effective and less toxic. The consortium is led by Dr. Paul A. Bunn, Jr., executive director of the IASLC and University of Colorado Cancer Center founding director. Dr. Wilbur Franklin, professor of pathology at the University of Colorado Denver and UCCC member, is the principal investigator.  Patients who wish to participate in the trial should contact Mary Jackson at 303-724-1650.